--- title: "Gastroparesis EXPEDITE | Sutter Health" description: "Examination of Programming with the Enterra® Therapy System (EXPEDITE) in a Double-Blinded, Randomized, Prospective Study in the Treatment of Nausea and Vomiting Symptoms Using Gastric Electrical Stimulation" url: "https://www.sutterhealth.org/research/clinical-trials/gastroparesis-expedite-2007479109" --- 1. [Home](https://www.sutterhealth.org/) / 2. [Research](https://www.sutterhealth.org/research) / 3. [Clinical trials](https://www.sutterhealth.org/research/clinical-trials) / 4. Gastroparesis EXPEDITE # Gastroparesis EXPEDITE **Status:** Open to Enrollment [Email us to enroll](https://www.sutterhealth.org/research/clinical-trials/gastroparesis-expedite-2007479109#enroll) #### Study details View study details on [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06560307). #### Locations - San Francisco #### Clinical trial FAQs Information for patients and study volunteers, including [frequently asked questions](https://www.sutterhealth.org/research/faqs). The purpose of this research study is to evaluate if an enhanced Enterra device programming strategy will improve symptoms associated with gastroparesis, improve symptoms in a faster amount of time, and improve quality of life measures. Participants in this study will be evaluated for study entry criteria, have an Enterra Therapy System implanted, and be randomly assigned to one of two programming strategies. Participants will answer daily questions about their gastroparesis symptoms on an application with their phone/tablet. Participants will answer quality of life questionnaires about their gastroparesis symptoms at monthly study visits. ![Mimi S Lin, M.D.](https://dyn.mktgcdn.com/p/ED1YhiH3a9rX8S9FhPHxsNFvAz-h---no5cA6dmYPts/fit=crop,gravity=auto,dpr=2,width=188,height=250,quality=100) Mimi S Lin, M.D. Principal investigator [View profile](https://www.sutterhealth.org/research/investigators/mimi-s-lin-md-2007479128) ## Email us to enroll - [Email San Francisco](mailto:ClinicalResearch%40sutterhealth.org?subject=More%20information%20on%20Gastroparesis%20EXPEDITE%20in%20San%20Francisco&body=Please%20be%20aware%20that%20if%20you%20reply%20with%20unencrypted%20email%2C%20this%20increases%20the%20risk%20that%20information%20could%20be%20read%20by%20an%20unauthorized%20third%20party.%20Please%20do%20not%20include%20any%20Protected%20Health%20Information%20in%20your%20email%20response.) ## Related clinical trials [View all clinical trials](https://www.sutterhealth.org/research-search-results?verticalKey=clinical_trial) - Clinical trial ### [Stress Urinary Incontinence PAS001 ProACT](https://www.sutterhealth.org/research/clinical-trials/stress-urinary-incontinence-pas001-proact-2080051902) Post Approval Study of the ProACT™ Adjustable Continence Therapy for Men **Status:** Open to Enrollment - Clinical trial ### [Chronic Nausea and Vomiting NAVIGATE](https://www.sutterhealth.org/research/clinical-trials/chronic-nausea-and-vomiting-navigate-2023207930) A Prospective Randomized Controlled Trial of Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System **Status:** Open to Enrollment - Clinical trial ### [Hepatitis LCAH3141 RE-AHFIRM](https://www.sutterhealth.org/research/clinical-trials/hepatitis-lcah3141-re-ahfirm-2075020771) RE-AHFIRM (RandomizEd Study of Larsucosterol in Alcohol-associated Hepatitis to Confirm saFety and effIcacy of tReatMent) **Status:** Open to Enrollment - Clinical trial ### [Kidney Transplant Patients EFC18554 FREXERA](https://www.sutterhealth.org/research/clinical-trials/kidney-transplant-patients-efc18554-frexera-2090973869) A Seamless Phase 2/3 Randomized, Open-label Study to Investigate Efficacy and Safety of Frexalimab Versus Tacrolimus in Adult Kidney Transplant Recipients **Status:** Coming Soon - Clinical trial ### [Microvascular Inflammation in Transplanted Kidney TRANSPIRE](https://www.sutterhealth.org/research/clinical-trials/microvascular-inflammation-in-transplanted-kidney-transpire-2048783395) A Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase 2 Trial Evaluating the Efficacy and Safety of Felzartamab in Recipients of Kidney Transplants With Late Isolated Microvascular Inflammation (MVI) **Status:** Open to Enrollment [View all clinical trials](https://www.sutterhealth.org/research-search-results?verticalKey=clinical_trial) ```json {"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]} ``` ```json {"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/clinical-trials/gastroparesis-expedite-2007479109#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Clinical trials","item":"https://www.sutterhealth.org/research/clinical-trials"},{"@type":"ListItem","position":4,"name":"Gastroparesis EXPEDITE"}]} ``` ```json {"@context":"https://schema.org","@type":"MedicalWebPage","@id":"https://www.sutterhealth.org/research/clinical-trials/gastroparesis-expedite-2007479109#medicalwebpage","name":"Gastroparesis EXPEDITE","description":"Examination of Programming with the Enterra® Therapy System (EXPEDITE) in a Double-Blinded, Randomized, Prospective Study in the Treatment of Nausea and Vomiting Symptoms Using Gastric Electrical Stimulation","url":"https://www.sutterhealth.org/research/clinical-trials/gastroparesis-expedite-2007479109","inLanguage":"en-US","dateModified":"2026-05-21","publisher":{"@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org"},"medicalAudience":{"@type":"MedicalAudience","audienceType":"Patient"},"mainEntity":{"@id":"https://www.sutterhealth.org/research/clinical-trials/gastroparesis-expedite-2007479109#medicaltrial"},"breadcrumb":{"@id":"https://www.sutterhealth.org/research/clinical-trials/gastroparesis-expedite-2007479109#breadcrumblist"},"mentions":[{"@type":"Person","name":"Mimi S Lin, M.D.","url":"https://www.sutterhealth.org/research/investigators/mimi-s-lin-md-2007479128","jobTitle":"Principal Investigator","affiliation":{"@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org"}}]} ``` ```json {"@context":"https://schema.org","@type":"MedicalTrial","@id":"https://www.sutterhealth.org/research/clinical-trials/gastroparesis-expedite-2007479109#medicaltrial","name":"Gastroparesis EXPEDITE","alternateName":"Examination of Programming with the Enterra® Therapy System (EXPEDITE) in a Double-Blinded, Randomized, Prospective Study in the Treatment of Nausea and Vomiting Symptoms Using Gastric Electrical Stimulation","url":"https://www.sutterhealth.org/research/clinical-trials/gastroparesis-expedite-2007479109","description":"The purpose of this research study is to evaluate if an enhanced Enterra device programming strategy will improve symptoms associated with gastroparesis, improve symptoms in a faster amount of time, and improve quality of life measures. Participants in this study will be evaluated for study entry criteria, have an Enterra Therapy System implanted, and be randomly assigned to one of two programming strategies. Participants will answer daily questions about their gastroparesis symptoms on an application with their phone/tablet. Participants will answer quality of life questionnaires about their gastroparesis symptoms at monthly study visits.","identifier":"NCT06560307","code":{"@type":"MedicalCode","codeValue":"NCT06560307","codingSystem":"ClinicalTrials.gov"},"sameAs":"https://clinicaltrials.gov/study/NCT06560307","status":"https://schema.org/Recruiting","healthCondition":[{"@type":"MedicalCondition","name":"Upper Gastrointestinal Disorders"}],"studyLocation":[{"@type":"AdministrativeArea","name":"San Francisco"}]} ```